The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

计划入组 52 人 · 首次发布于 2024 年 5 月 1 日

The Balance Recovery Confidence (Brc) Scale

计划入组 95 人 · 首次发布于 2024 年 6 月 5 日

Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants

计划入组 50 人 · 首次发布于 2026 年 7 月 13 日

BRC-001

BRC-002

BRC-003

Blackrock Silver Corp

Canada

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

BRC Therapeutics Appoints Veteran Pharma Executive Ron Eastman to Board of Directors

CU Anschutz Launches Phase 2 Trial of CBD Formulation for Restless Legs Syndrome

Cannabis Drug Companies Eye IPOs and Private Funding Following U.S. Rescheduling to Schedule III